[Use of Navoban in pediatric oncology].
In the course of treatment for tumors and recurrences, 86 children, aged 4-16 years, received polychemotherapy which induced excessive vomiting. Navoban (tropisetron) was administered to control vomiting. Total or partial control of nausea and vomiting was observed in 94.1%. No side-effects were registered.
Safonova
S A
SA
Kolygin
B A
BA
Punanov
I A
IA
Borodina
A F
AF
D000293:Adolescent; D000932:Antiemetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D016896:Treatment Outcome; D000077526:Tropisetron; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
D000932:Antiemetics; D000970:Antineoplastic Agents; D007211:Indoles; D000077526:Tropisetron